Filing Analysis
Material Agreement
Filed Apr 13, 2026
HIGH
Boundless Bio, Inc. entered into an agreement to terminate its 80,168 square foot laboratory and office lease in San Diego effective May 31, 2026, more than eight years ahead of the original 2034 expiration date. The company will incur a $10.0 million termination payment and forfeit a $0.5 million security deposit to exit the agreement.
Red Flags
- Significant cash outflow of $10.5 million for a non-operational expense.
- Abrupt exit from a long-term facility commitment eight years early, suggesting a major pivot or downsizing.
- Forfeiture of the entire security deposit.
Key Facts
- Lease termination for 80,168 rentable square feet at 10955 Alexandria Way, San Diego.
- The lease was originally scheduled to expire on October 31, 2034.
- The company must pay a $10.0 million lease modification payment.
- The landlord will retain the full $0.5 million security deposit.
- The termination was contingent on the landlord securing a new tenant, a condition that has been satisfied.
- The effective termination date is May 31, 2026.
Officer Departure
Filed Mar 09, 2026
LOW
Boundless Bio, Inc. reported its Q4 and full-year 2025 financial results and announced the resignation of board member Dr. Christine Brennan. Dr. Brennan's departure is effective March 3, 2026, and is not due to any disagreement with the company.
Key Facts
- Financial results for the fourth quarter and full year ended December 31, 2025, were released on March 9, 2026.
- Dr. Christine Brennan resigned from the Board of Directors effective March 3, 2026.
- The resignation is attributed to Dr. Brennan assuming a new role at Johnson & Johnson Development Corporation.
- The company stated there were no disagreements regarding operations, policies, or practices.
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.